Open AccessLong Overall Survival in Ceritinib-Treated ALK-Positive Lung Cancer
Author(s) -
Peter M. Goodwin
Publication year - 2018
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000549786.87785.de
Subject(s) - ceritinib , crizotinib , medicine , anaplastic lymphoma kinase , alk inhibitor , lung cancer , oncology , pemetrexed , chemotherapy , cohort , surgery , cisplatin , malignant pleural effusion